From Ross Givens:
This is probably the most exciting insider activity I've seen this year.
Why?
Well, the CEO of this firm just scooped up one million dollars worth of stock in his personal account.
But this is no ordinary CEO.
In fact, this man boasts one of the most impressive track records when it comes to biotech investing that I've ever seen.
He's been involved in more than $40 BILLION in corporate biotech acquisitions…
35 initial public offerings…
And he's served on 25 corporate boards.
So it's safe to say he knows a thing or two about the biotech industry.
And what's more?
His current open biotech stock positions include +866% on AVEO Pharmaceuticals…
+361% on Genocea Biosciences…
+469% on Mersana Therapeutics…
And +1,305% on Adaptimmune Therapeutics stock that he just bought in January!
I'm telling you, when an investor as sophisticated as this guy dumps a million into a stock…
It's worth paying attention to.
Click right here to watch a video and get the full scoop on this rare opportunity…
And learn how you can get on board before it potentially pops!
All the best,
Ross Givens
Editor, Insider Report
No comments:
Post a Comment